case_id,mode,iteration,Q8_reasoning,has_no_in_pred
Case8288,baseline,iter2,"Under UHC criteria, prenatal WES is covered for major structural fetal anomalies when prior CMA is nondiagnostic, counseling has occurred, and results may impact management; all these conditions are met in this case.",False
Case2847,baseline,iter2,"Under BCBS FEP coverage rules, WES is covered here: an infant with a high‑risk unexplained event suggesting a genetic etiology, nondiagnostic CMA, documented genetic counseling, and relevant family history—all criteria for medical necessity are met.",False
Case8621,baseline,iter2,"Clinical indications (pediatric autism/neurodevelopmental disorder), prior nondiagnostic CMA, and documented pre‑test genetic counseling align with UHC WES coverage criteria; no explicit disqualifying factors are present in the provided information.",False
Case14141,baseline,iter2,"Under FEP criteria, WES is covered for patients with unexplained multiple congenital anomalies and developmental delay when prior CMA is nondiagnostic, genetic counseling is completed, and there is relevant family history; all those elements are documented for this 7-year-old patient.",False
Case6747,baseline,iter2,"All applicable BCBS_FEP coverage criteria are met: appropriate clinical indication (multiple congenital anomalies), prior CMA nondiagnostic, ordering provider is a medical geneticist, family history supportive, and genetic counseling documented; therefore WGS is covered.",False
Case811,baseline,iter2,"Under BCBS_FEP criteria the infant meets medical‑necessity indications (early severe neurologic/movement disorder), had required prior CMA testing nondiagnostic, has relevant family history, and completed genetic counseling — therefore WES is covered.",False
Case9408,baseline,iter2,"Under FEP criteria the patient meets clinical indication (early-onset epileptic encephalopathy), prior required testing (nondiagnostic CMA) is documented, the order is from a medical geneticist, and genetic counseling was completed—therefore WES is covered.",False
Case17929,baseline,iter2,"Based on UHC coverage criteria: the child meets a covered clinical indication (major congenital/organ system abnormality), prior karyotype was nondiagnostic, counseling documented, and no disqualifying factors are present; therefore CMA is covered.",True
Case12834,baseline,iter2,"Per Cigna coverage policy, CMA is medically necessary for individuals with unexplained developmental delay/intellectual disability/ASD or multiple congenital anomalies. The 16-year-old has a complex neurodevelopmental disorder and prior Fragile X testing was nondiagnostic, so CMA meets coverage criteria.",False
Case4604,baseline,iter2,"Under BCBS_FEP criteria WES is covered for unexplained developmental delay/intellectual disability after nondiagnostic CMA; the patient meets medical indication, required prior CMA was nondiagnostic, genetic counseling documented, and relevant family history is present, supporting coverage.",False
Case19255,baseline,iter2,"Based on UHC coverage criteria: the patient has a qualifying personal history (two separate primary breast cancers), relevant family history (father with metastatic prostate cancer), and documented pre-test genetic counseling. These factors meet medical necessity and counseling requirements for BRCA1/2 testing, so the test is covered.",False
Case2211,baseline,iter2,"Under UHC BRCA coverage criteria the combination of a known familial BRCA2 pathogenic variant, the patient’s personal/family cancer history, adult age, and documented pre‑test counseling satisfies coverage requirements.",False
Case3359,baseline,iter2,"Based on UHC coverage criteria: pediatric patient with unexplained developmental delay/hypotonia, nondiagnostic prior CMA, appropriate ordering provider involvement, documented genetic counseling, and relevant family history — all criteria for WES coverage are met.",False
Case22,baseline,iter2,"Applying BCBS FEP medical policy: the patient has a covered clinical indication (personal metastatic high-risk prostate cancer with intraductal/cribriform histology and a positive family history), documented pre-test counseling, and no disqualifying prior-test requirements—BRCA1/2 testing is therefore covered.",False
Case5605,baseline,iter2,"All applicable BCBS_FEP criteria are met: pediatric age, appropriate medical indication (major congenital cardiac anomaly), nondiagnostic prior CMA, and documented pre-test genetic counseling — therefore WGS is covered.",True
Case3677,baseline,iter2,"The patient meets UHC clinical coverage criteria (personal breast cancer plus strong family history of BRCA-related cancers), has documented pre-test counseling, and ordering clinician is within typical authorized providers, so BRCA1/2 testing is covered.",False
Case13517,baseline,iter2,"Applying UHC coverage criteria: the patient has a clinically appropriate indication (suspected inborn error of metabolism with an affected sibling), pre-test genetic counseling is documented, and WES is an appropriate next-step diagnostic test in this context, so the test meets medical necessity and is covered.",False
Case15820,baseline,iter2,"Per Cigna policy, CMA is covered for unexplained developmental delay/intellectual disability; the patient meets the medical indication, no disqualifying age/provider/prior-test requirements apply, and counseling has been completed.",False
Case7376,baseline,iter2,"Patient meets UHC coverage criteria: unexplained major abnormality suggesting genetic etiology, prior targeted testing nondiagnostic, pre-test genetic counseling documented, and appropriate provider involvement; therefore WES is covered.",False
Case19321,baseline,iter2,"All applicable UHC coverage criteria are met: pediatric age, appropriate medical indication (complex neurodevelopmental disorder with ASD features), required prior CMA completed and nondiagnostic, ordering clinician is appropriate neurologist, and pre‑test genetic counseling documented.",False
Case6867,baseline,iter2,"Applying BCBS_FEP BRCA coverage criteria to the facts: the patient has qualifying family history (brother with intraductal metastatic prostate cancer; mother with breast cancer at age 50) and has documented pre‑test genetic counseling. Although age at the patient's breast cancer diagnosis is not provided, the available family and personal history meet BCBS_FEP indications for BRCA testing, so the test is covered.",False
Case13406,baseline,iter2,"Per UHC coverage criteria the patient meets medical indication (global developmental delay), required prior testing (nondiagnostic CMA), an appropriate ordering provider (medical geneticist), and counseling documentation — therefore WGS is covered.",False
Case5834,baseline,iter2,"Patient meets clinical indication for CMA (unexplained severe intellectual disability), counseling was completed, no disqualifying age or prior‑test requirements apply under BCBS FEP policy; therefore CMA is covered.",False
Case11795,baseline,iter2,"Under BCBS_FEP criteria, WES is covered for pediatric patients with suspected genetic conditions when prior CMA is nondiagnostic, clinical indications (suspected channelopathy/arrhythmia/cardiomyopathy) are present, pre‑test counseling is documented, and family history supports a genetic etiology. All these coverage criteria are met.",False
Case2007,baseline,iter2,"Based on BCBS_FEP criteria (personal history of breast cancer, first-degree relative with early-onset breast cancer, appropriate counseling completed, appropriate ordering provider and age), BRCA1/2 testing is medically necessary and covered.",False
Case2666,baseline,iter2,Based on FEP BRCA coverage criteria the patient is an adult with a first-degree relative with metastatic prostate cancer and has documented pre-test genetic counseling; these elements meet policy criteria for coverage of germline BRCA1/2 testing.,False
Case15458,baseline,iter2,"Based on BCBS_FEP coverage criteria the patient meets age, clinical indication, family-history, counseling, and ordering-provider requirements for BRCA1/2 germline testing, so the test is covered.",False
Case5674,baseline,iter2,"Under BCBS_FEP coverage logic the patient meets clinical indication (pediatric persistent unexplained seizures), has required prior testing (nondiagnostic CMA), has documented genetic counseling and follow-up arrangements, and has relevant family history — overall supporting coverage of WES.",False
Case9773,baseline,iter2,"Under FEP coverage criteria CMA is covered for evaluation of unexplained intellectual disability/developmental delay. The patient is a 2‑year‑old with severe intellectual disability, no prior testing is required, the test was ordered by an appropriate provider, and pre‑test counseling was completed, supporting coverage.",False
Case8288,baseline,iter3,"Under UHC policy, WES is covered for a fetus with a major structural anomaly when CMA is nondiagnostic and appropriate counseling/ordering clinician documentation exists; all these conditions are met in the provided information.",False
Case3422,baseline,iter3,"Based on Cigna criteria: patient has a congenital anomaly (choanal atresia), prior nondiagnostic CMA, documented genetic counseling, and clinical suspicion of a genetic etiology — together these meet Cigna's coverage requirements for WES.",False
Case2847,baseline,iter3,"Based on BCBS FEP coverage criteria (infant with severe unexplained life‑threatening event, CMA nondiagnostic, documented genetic counseling, appropriate ordering), WES is medically necessary and covered for this patient.",False
Case8621,baseline,iter3,"Under UHC WES coverage criteria the patient meets key requirements: appropriate medical indication (complex neurodevelopmental disorder/autism), prior CMA nondiagnostic, relevant family history, and documented pre-test genetic counseling. Therefore the test is covered.",False
Case14141,baseline,iter3,"Per FEP coverage rules, WES is covered for patients with unexplained multiple congenital anomalies/developmental disorders after nondiagnostic CMA; prior CMA was nondiagnostic, counseling is documented, and family history supports testing, so the request meets coverage criteria.",False
Case6747,baseline,iter3,"Applying BCBS_FEP coverage rules: patient meets age, specialist ordering, medical indication (multiple congenital anomalies, suspected genetic etiology), prior CMA nondiagnostic, family history, and counseling—therefore WGS is covered.",False
Case811,baseline,iter3,"Under BCBS_FEP WES policy, the patient meets coverage requirements: appropriate pediatric age/clinical indication (early severe movement disorder and possible syndromic features), prior CMA nondiagnostic, documented genetic counseling, and relevant family history; therefore WES is covered.",False
Case9408,baseline,iter3,"Per FEP WES coverage criteria the patient meets indication (early‑onset epileptic encephalopathy), required prior testing (nondiagnostic CMA), ordering provider (medical geneticist), and counseling requirements, so the test is covered.",True
Case17929,baseline,iter3,"Based on UHC coverage criteria: pediatric patient with a major congenital/structural abnormality, prior nondiagnostic karyotype, and neurologist/genetics involvement — CMA meets medical necessity and is covered.",False
Case12834,baseline,iter3,Patient meets Cigna's medical necessity criteria for CMA (16-year-old with complex neurodevelopmental disorder affecting ≥1 organ system; prior Fragile X nondiagnostic). Coverage is expected provided the specimen/test is correctly submitted as a germline constitutional CMA (the requisition should be corrected from tumor-type to germline for appropriate coverage/billing).,False
Case4604,baseline,iter3,"Based on BCBS_FEP criteria: pediatric unexplained DD/ID, nondiagnostic CMA, relevant family history, and documented pre-test genetic counseling support medical necessity for WES; thus the test is covered pending any remaining required targeted testing (not documented) or standard administrative checks.",False
Case19255,baseline,iter3,"Based on UHC-style coverage criteria: the patient meets clinical indications (two primary breast cancers and age <50), has relevant family history, pre-test counseling is documented, and an appropriate ordering provider is involved — therefore BRCA1/2 testing is covered.",False
Case2211,baseline,iter3,"Based on UHC coverage rules, the presence of a known BRCA2 pathogenic variant in a first-degree relative plus the patient's personal cancer history and completed pre-test genetic counseling meets medical necessity for targeted BRCA testing; therefore the test is covered.",False
Case14408,baseline,iter3,"Patient meets Cigna family-history medical indication for BRCA testing (first-degree relative with male breast cancer), pre-test counseling documented, and no disqualifying factors are present; therefore test is covered under applicable BRCA coverage criteria.",False
Case9349,baseline,iter3,"Under BCBS_FEP criteria WES is covered when there is a suspected genetic etiology for a congenital anomaly, relevant family history suggesting inherited disease, and appropriate genetic counseling. The patient is a 5-year-old with a congenital cardiac anomaly, a paternal uncle with sudden unexplained death <35, nondiagnostic prior (FISH) testing, completed pre-test counseling, and planned follow-up—together meeting payer medical necessity and coverage requirements.",False
Case3359,baseline,iter3,"All applicable UHC coverage criteria are met: appropriate pediatric age, qualifying clinical indications (developmental delay/hypotonia), prior nondiagnostic CMA completed, relevant family history, appropriate ordering provider and documented genetic counseling—therefore WES is covered.",False
Case22,baseline,iter3,"From a BCBS_FEP adjudication perspective the patient meets medical necessity (metastatic high-risk prostate cancer), has relevant family history, and has completed required pre-test counseling; therefore BRCA1/2 germline testing is covered.",False
Case5605,baseline,iter3,"The patient meets clinical-necessity criteria for WGS (major congenital anomaly), has a nondiagnostic prior CMA, and completed pre-test genetic counseling — aligning with BCBS_FEP coverage requirements for WGS/WES, so the test is covered.",True
Case19162,baseline,iter3,"Under BCBS_FEP criteria the neonate meets age, ordering-provider, clinical indication, family-history and counseling requirements for WGS; prior testing does not preclude coverage in this critically affected neonate. Therefore WGS is covered.",False
Case16487,baseline,iter3,"Under UHC criteria the neonate has a covered indication: recurrent high‑risk BRUE with nondiagnostic targeted testing, relevant family history, completed pre‑test counseling and plan for follow‑up. Age and documentation meet coverage requirements for WES.",False
Case3677,baseline,iter3,"Based on UHC BRCA coverage criteria: the patient has a personal history of breast cancer, a close relative with pancreatic cancer, multiple affected maternal relatives, and documented pre-test genetic counseling. These elements satisfy clinical and counseling requirements, supporting coverage.",False
Case13517,baseline,iter3,"Based on UHC coverage principles: the patient has a clinical suspicion of a genetic/inborn error (conjugated hyperbilirubinemia) plus a sibling with suggestive labs (affected family member), pre-test genetic counseling was completed, and WES is an appropriate diagnostic modality for suspected metabolic/genetic disorders. These factors meet medical necessity criteria for coverage.",False
Case15820,baseline,iter3,"Per Cigna coverage for CMA, the patient meets medical necessity (unexplained DD/ID), has documented pre‑test genetic counseling, no age restriction applies, and therefore CMA is covered for this presentation.",False
Case7376,baseline,iter3,"Based on UHC criteria applied to this case: adult with unexplained major abnormality suspected to be genetic, prior targeted testing (FISH) nondiagnostic, ordering physician involvement and documented pre-test genetic counseling — WES meets medical necessity and is covered.",False
Case19321,baseline,iter3,"Based on UHC WES coverage criteria: appropriate medical indication (pediatric neurodevelopmental disorder/ASD features), required prior testing (CMA) completed and nondiagnostic, appropriate ordering provider (neurologist), and documented pre-test genetic counseling — the request meets coverage criteria.",False
Case6867,baseline,iter3,Under BCBS FEP hereditary cancer testing criteria the combination of the patient's personal history of breast cancer plus relevant first‑degree relatives (mother with breast cancer at 50; brother with metastatic prostate with intraductal features) and documented pre‑test counseling supports medical necessity and coverage for BRCA1/2 testing.,False
Case1130,baseline,iter3,"Based on UHC criteria: the patient has persistent unexplained seizures (clinical indication), prior targeted testing (FISH) was nondiagnostic, documented genetic counseling is present, and no disqualifying age or ordering-provider restrictions apply—therefore WES is covered.",False
Case13406,baseline,iter3,"Under UHC comprehensive genomic sequencing policy the criteria are met: appropriate clinical indication (GDD), required prior testing (nondiagnostic CMA) completed, ordered by a medical geneticist, and pre-test genetic counseling documented — therefore WGS is covered.",False
Case5834,baseline,iter3,"Under BCBS FEP coverage criteria CMA is medically necessary for unexplained intellectual disability/developmental disorder; the patient meets the clinical indication, pre‑test counseling is documented, and no prior tests or restrictive provider requirements block coverage.",False
Case11795,baseline,iter3,"Under BCBS_FEP WES policy the patient meets coverage criteria: clinically suspected genetic disorder (abnormal ECG/possible channelopathy), prior CMA nondiagnostic, supportive family history, and documented pre-test counseling — therefore WES is covered.",False
Case2007,baseline,iter3,"Based on BCBS_FEP coverage criteria: patient has personal early-onset breast cancer, relevant first-degree family history, documented pre-test counseling, and no unmet prior-test requirements — BRCA1/2 testing is covered.",False
Case2666,baseline,iter3,"Based on FEP coverage criteria the patient is an unaffected adult with a first-degree relative (father) who has metastatic prostate cancer (a BRCA-associated cancer), pre-test genetic counseling was completed, and no disqualifying prior-test or provider issues exist — therefore BRCA1/2 testing is covered.",False
Case13983,baseline,iter3,"Based on BCBS_FEP coverage criteria applied to this case: the patient is an infant with a significant clinical presentation (abnormal ECG and high‑risk BRUE), supportive family history, pre‑test genetic counseling completed, and prior targeted testing nondiagnostic. These factors meet medical necessity criteria for WGS, so the test is covered.",False
Case15458,baseline,iter3,"Applying BCBS_FEP BRCA coverage rules: the patient has a personal history of breast cancer plus family members with ovarian and prostate cancers (BRCA-associated), completed pre-test counseling, and the test was ordered by an acceptable provider—thus medical necessity and administrative requirements are met and coverage is indicated.",False
Case5674,baseline,iter3,"Under BCBS FEP criteria, WES is medically indicated for a pediatric patient with persistent unexplained seizures, nondiagnostic CMA, relevant family history, and documented genetic counseling; these elements support coverage.",False
Case9773,baseline,iter3,"Under BCBS FEP criteria, CMA is covered for individuals with unexplained intellectual disability/developmental delay. The 2‑year‑old has severe intellectual disability, no prior testing is required, pre‑test counseling is completed, and the order is from an appropriate treating clinician, so coverage is supported.",False
Case10451,baseline,iter1,"From a UHC coverage-adjudication perspective the patient meets the clinical indication (unexplained moderate–severe intellectual disability), has required prior CMA testing documented as nondiagnostic, and the order is placed by an appropriate specialist (neurology); therefore WES is covered.",True
Case8288,baseline,iter1,"Clinical indication (prenatal major cardiac anomaly), nondiagnostic prior CMA, documented genetic counseling, and relevant family history meet UHC WES coverage criteria. (Final approval would be contingent on verification of the ordering provider per UHC policy.)",False
Case2847,baseline,iter1,"From a BCBS FEP coverage adjudication perspective the patient meets age, medical necessity (severe unexplained early‑onset event), prior testing (CMA nondiagnostic), family history, and counseling requirements — WES is therefore covered.",False
Case8621,baseline,iter1,"Per UHC criteria the patient has an appropriate clinical indication (complex neurodevelopmental disorder/autism), required prior testing (nondiagnostic CMA) is documented, genetic counseling is completed, and relevant family history is present — together these meet coverage criteria for WES.",False
Case14141,baseline,iter1,"Per BCBS FEP WES coverage criteria: the patient has a compatible clinical indication (multiple congenital anomalies/developmental concerns), prior CMA was nondiagnostic, pre‑test counseling documented, and supportive family history—thus the test meets FEP medical necessity criteria and is covered.",False
Case6747,baseline,iter1,"All BCBS_FEP coverage criteria are met: appropriate age, qualifying clinical indication (multiple congenital anomalies), nondiagnostic prior CMA, ordering by a medical geneticist, relevant family history, and completed pre-test counseling — therefore WGS is covered.",False
Case811,baseline,iter1,"Under BCBS FEP policy the case meets coverage criteria: infant with early-onset movement/neurologic disorder and family history of congenital anomalies, prior nondiagnostic CMA, and documented pre-test genetic counseling; therefore WES is medically necessary and covered.",False
Case9408,baseline,iter1,"Under Blue Cross Blue Shield FEP criteria the patient meets indication (early-onset epileptic encephalopathy), required prior testing (nondiagnostic CMA), ordering provider requirements (medical geneticist), and counseling requirements; therefore WES is covered.",True
Case17929,baseline,iter1,"Under UHC coverage criteria CMA is covered for evaluation of unexplained major congenital/structural abnormalities or multisystem findings; this patient has a major organ system abnormality and a nondiagnostic karyotype, meets medical necessity, and therefore the requested CMA is covered.",False
Case4604,baseline,iter1,"All key BCBS_FEP coverage criteria are met: appropriate clinical indication (unexplained DD/ID), required prior CMA nondiagnostic, relevant family history, and documented pre‑test genetic counseling — therefore WES is covered.",False
Case19255,baseline,iter1,"Based on UHC coverage criteria (multiple primary breast cancers, early age, relevant family history) plus documented pre-test genetic counseling, BRCA1/2 testing is medically indicated and covered.",False
Case2211,baseline,iter1,"Patient meets payer clinical criteria (known familial BRCA2 pathogenic variant, multiple affected relatives, personal cancer history), counseling is documented, and the appropriate targeted familial-variant test (81162) would be covered by UHC.",False
Case14408,baseline,iter1,"Based on Cigna coverage criteria the patient meets a covered family‑history indication (first‑degree relative with male breast cancer), has documented pre‑test counseling, and no disqualifying age/provider/prior‑test barriers are present; therefore BRCA1/2 testing is covered.",False
Case3359,baseline,iter1,"Based on UHC coverage criteria applied to this case: pediatric patient with unexplained developmental delay and hypotonia, nondiagnostic CMA, appropriate specialist involvement and documented pre‑test genetic counseling — WES meets medical necessity and is covered. (Final coverage contingent on any additional payer‑required prior tests, e.g., Fragile X in males, if applicable.)",False
Case22,baseline,iter1,"Based on BCBS_FEP coverage applied to the patient's facts: metastatic high-risk prostate cancer with intraductal/cribriform histology, relevant family history, documented pre-test counseling, and no disqualifying age or prior-test requirements — BRCA1/2 testing is medically necessary and covered.",False
Case5605,baseline,iter1,"Under BCBS_FEP WES/WGS criteria the patient meets medical necessity: pediatric major congenital anomaly, nondiagnostic CMA, and documented pre‑test genetic counseling; therefore WGS is covered.",False
Case16487,baseline,iter1,"Under UHC coverage principles for diagnostic WES, the infant has an appropriate clinical indication (recurrent unexplained neonatal BRUE), prior targeted testing was nondiagnostic (FISH), pre-test counseling completed, and supportive family history—together meeting coverage criteria for WES.",False
Case3677,baseline,iter1,"Applying UHC BRCA coverage criteria: the patient has a personal history of breast cancer, is age 46 (within common age-based thresholds), has a strong family history including pancreatic cancer, and has completed pre-test genetic counseling — together these satisfy UHC medical-necessity and counseling requirements for coverage.",False
Case11514,baseline,iter1,"Clinical indications (early‑onset cholestasis, suspected metabolic/genetic etiology, nondiagnostic CMA, relevant family history) meet UHC medical necessity criteria for WES. The only policy deficiency is absent documented pre‑test counseling, which may require remediation but does not negate medical necessity for coverage if counseling is documented or completed per payer process.",True
Case13517,baseline,iter1,"Based on UHC coverage criteria for pediatric patients with suspected genetic disorders (age met), presence of a relevant affected sibling, documented pre-test genetic counseling, and an appropriate clinical indication (unexplained conjugated hyperbilirubinemia suspicious for an IEM), WES meets coverage criteria.",False
Case15820,baseline,iter1,"Per Cigna policy, CMA is covered for unexplained developmental delay/intellectual disability. The patient meets the clinical indication, has no disqualifying age or prior‑test requirements, the ordering physician is appropriate, and counseling was performed.",False
Case19321,baseline,iter1,"All applicable UHC coverage criteria are met: pediatric age, appropriate clinical indication (complex NDD/ASD), prior nondiagnostic CMA, specialist ordering provider (neurologist), and pre-test genetic counseling — therefore WES is covered.",False
Case6867,baseline,iter1,"Based on BCBS_FEP coverage rules: qualifying personal history of breast cancer, relevant first‑degree family history (metastatic prostate in brother and mother with early breast cancer), and documented pre‑test genetic counseling, the requested BRCA1/2 test meets medical necessity and is covered.",False
Case13406,baseline,iter1,"Applying UHC coverage criteria: the patient is pediatric (6 weeks) with unexplained global developmental delay, prior CMA was nondiagnostic, the ordering provider is a medical geneticist, and pre-test counseling was completed — collectively meeting UHC medical necessity and coverage requirements for WGS.",False
Case5834,baseline,iter1,"Under BCBS FEP criteria CMA is covered for unexplained intellectual disability/developmental delay, the patient meets the clinical indication, pre‑test genetic counseling is documented, and no disqualifying age or prior‑test requirements apply.",False
Case11795,baseline,iter1,"Under BCBS_FEP WES coverage criteria the infant meets age and clinical indication requirements (serious neonatal cardiac findings, prior nondiagnostic CMA), required prior testing is complete, pre‑test counseling documented, and the appropriate CPT (81415) is identified — overall supporting coverage of WES.",False
Case2007,baseline,iter1,"Per BCBS_FEP coverage criteria the patient meets medical indications (personal early-onset breast cancer and qualifying family history), has required pre-test counseling documented, and no disqualifying prior-test requirements apply; therefore BRCA1/2 testing is covered.",False
Case2666,baseline,iter1,She meets FEP medical-necessity family-history criteria (first-degree relative with metastatic prostate cancer) and has documented pre-test genetic counseling; therefore BRCA1/2 testing is covered.,False
Case13983,baseline,iter1,"Under BCBS_FEP coverage principles, WGS is considered medically necessary for infants with a suspected genetic disorder that is likely to affect acute management (significant abnormal ECG raising concern for channelopathy/arrhythmia/cardiomyopathy), family history, and when prior testing is nondiagnostic. Pre‑test genetic counseling is documented. Although additional prior tests (e.g., CMA or targeted panels) are not all documented, the clinical urgency and potential management impact support coverage.",True
Case15458,baseline,iter1,"Under BCBS_FEP BRCA coverage criteria the patient meets medical necessity (very early-onset breast cancer plus supporting family history), counseling requirements are met, and no disqualifying prior-test or provider restrictions apply — test is covered.",False
Case5674,baseline,iter1,"Under BCBS_FEP WES criteria the patient meets age, medical indication (persistent suspected genetic epilepsy), required prior testing (nondiagnostic CMA), documented genetic counseling, and genetics involvement, therefore WES is covered.",False
Case9773,baseline,iter1,"Under FEP policy the patient meets covered clinical indication (severe intellectual disability), pre‑test counseling is documented, no disqualifying age or prior‑test requirements apply, and the appropriate CPT is 81228 — therefore the CMA is covered.",False
